loader image
Saturday, February 22, 2025
40.5 F
McAllen
We Welcome your Press Release
- Advertisement -

How to Fight Medicare Fraud & Protect your Identity

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

Happy National Consumer Protection Week! Now’s a great time to brush up on your Medicare rights and protections, and take action to protect your identity.

Here are 3 things to do:

  1. Protect your identity. Identity theft happens when someone uses your personal information without your consent to commit fraud or other crimes. Guard your Medicare Number and card, and keep your Social Security Number safe.
  2. Help fight Medicare fraud. Use your MyMedicare account to stay on top of your claims. If you find errors or fraud, report it to us. Don’t have a MyMedicare account yet? Sign up for free at MyMedicare.govtoday.
  3. Know your rights. You have certain rights and protections designed to make sure you get the health care services the law says you can get.

Sincerely, The Medicare Team

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

UPDATE: Measles Outbreak

Mega Doctor News Mega Doctor News  As of February 18, 2025, the Texas...

DHR Health Celebrates 100th Ion Robotic-Assisted Bronchoscopy

DHR Health, a leader in healthcare serving the Rio Grande Valley, announced today that Dr. Federico Vallejo, pulmonologist, has successfully performed his 100th Ion robotic-assisted bronchoscopy.

DHR Health: Pioneering Alzheimer’s Treatment Breakthrough South of San Antonio

DHR Health, a leader in healthcare innovation, proudly announced today its groundbreaking achievement as the first hospital south of San Antonio to successfully administer Leqembi, an FDA-approved medication for the early treatment of Alzheimer’s disease. This milestone demonstrates their expertise and is a significant advancement in healthcare for the Rio Grande Valley.

FDA Approves First CRISPR Gene Therapy to Treat Sickle Cell Disease

Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older.
- Advertisement -
×